A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment

OBJECTIVE To study the association between gastrointestinal colonization of carbapenemase-producing Enterobacteriaceae (CPE) and proton pump inhibitors (PPIs). METHODS We analyzed 31,526 patients with prospective collection of fecal specimens for CPE screening: upon admission (targeted screening) and during hospitalization (opportunistic screening, safety net screening, and extensive contact tracing), in our healthcare network with 3,200 beds from July 1, 2011, through December 31, 2015. Specimens were collected at least once weekly during hospitalization for CPE carriers and subjected to broth enrichment culture and multiplex polymerase chain reaction. RESULTS Of 66,672 fecal specimens collected, 345 specimens (0.5%) from 100 patients (0.3%) had CPE. The number and prevalence (per 100,000 patient-days) of CPE increased from 2 (0.3) in 2012 to 63 (8.0) in 2015 (P<.001). Male sex (odds ratio, 1.91 [95% CI, 1.15–3.18], P=.013), presence of wound or drain (3.12 [1.70–5.71], P<.001), and use of cephalosporins (3.06 [1.42–6.59], P=.004), carbapenems (2.21 [1.10–4.48], P=.027), and PPIs (2.84 [1.72–4.71], P<.001) in the preceding 6 months were significant risk factors by multivariable analysis. Of 79 patients with serial fecal specimens, spontaneous clearance of CPE was noted in 57 (72.2%), with a median (range) of 30 (3–411) days. Comparing patients without use of antibiotics and PPIs, consumption of both antibiotics and PPIs after CPE identification was associated with later clearance of CPE (hazard ratio, 0.35 [95% CI, 0.17–0.73], P=.005). CONCLUSIONS Concomitant use of antibiotics and PPIs prolonged duration of gastrointestinal colonization by CPE. Infect Control Hosp Epidemiol 2016;1418–1425

[1]  V. Cheng,et al.  Implementation of directly observed patient hand hygiene for hospitalized patients by hand hygiene ambassadors in Hong Kong. , 2016, American journal of infection control.

[2]  C. Seas,et al.  Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries , 2016, PloS one.

[3]  X. Xia,et al.  Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China , 2016, Annals of Clinical Microbiology and Antimicrobials.

[4]  M. Balice,et al.  Risk factors for carbapenemase-producing Enterobacteriaceae colonization of asymptomatic carriers on admission to an Italian rehabilitation hospital. , 2016, The Journal of hospital infection.

[5]  J. H. Chen,et al.  Gastrointestinal colonization with multiple New Delhi metallo-β-lactamase-producing Enterobacteriaceae isolates in the same patient: a potential challenge in outbreak investigation. , 2016, The Journal of hospital infection.

[6]  V. Cheng,et al.  Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  Tim D Spector,et al.  Proton pump inhibitors alter the composition of the gut microbiota , 2015, Gut.

[8]  I. Nováková,et al.  Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management. , 2015, American journal of infection control.

[9]  J. H. Chen,et al.  Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii , 2015, European Journal of Clinical Microbiology and Infectious Diseases.

[10]  V. Cheng,et al.  Hand-touch contact assessment of high-touch and mutual-touch surfaces among healthcare workers, patients, and visitors. , 2015, The Journal of hospital infection.

[11]  J. Rossen,et al.  An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  V. Cheng,et al.  Effect of proactive infection control measures on benchmarked rate of hospital outbreaks: An analysis of public hospitals in Hong Kong over 5 years , 2015, American Journal of Infection Control.

[13]  J. Rubin,et al.  Carbapenemase Producing Bacteria in the Food Supply Escaping Detection , 2015, PloS one.

[14]  Michael Y. Lin,et al.  Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  K. Yuen,et al.  Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China , 2015, Emerging Microbes & Infections.

[16]  C. Yip,et al.  Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  T. Marrie,et al.  Recurrent Pneumonia: A Review with Focus on Clinical Epidemiology and Modifiable Risk Factors in Elderly Patients , 2015, Drugs & Aging.

[18]  V. Cheng,et al.  Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

[19]  Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study. , 2014, American journal of infection control.

[20]  B. Guerra,et al.  An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. , 2014, Veterinary microbiology.

[21]  B. Li,et al.  Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. , 2014, American journal of infection control.

[22]  T. Eckmanns,et al.  Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. , 2014, American journal of infection control.

[23]  E. di Giulio,et al.  Proton pump inhibitor therapy and potential long-term harm , 2014, Current opinion in endocrinology, diabetes, and obesity.

[24]  K. To,et al.  Proactive infection control measures to prevent nosocomial transmission of carbapenem‐resistant Enterobacteriaceae in a non‐endemic area , 2013, Chinese medical journal.

[25]  D. Shen,et al.  A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  D. Calfee,et al.  Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity , 2013, Infection Control &#x0026; Hospital Epidemiology.

[27]  N. Woodford,et al.  Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. , 2013, Journal of medical microbiology.

[28]  Matthaios Papadimitriou-Olivgeris,et al.  Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. , 2012, The Journal of antimicrobial chemotherapy.

[29]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[30]  V. Cheng,et al.  Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. , 2012, Chinese medical journal.

[31]  N. Woodford,et al.  Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. , 2012, The Journal of antimicrobial chemotherapy.

[32]  D. Adler,et al.  Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis , 2012, The American Journal of Gastroenterology.

[33]  R. Cavallazzi,et al.  Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis , 2012, The American Journal of Gastroenterology.

[34]  V. Cheng,et al.  Emergence of NDM-1-producing Enterobacteriaceae in China. , 2012, The Journal of antimicrobial chemotherapy.

[35]  R. Weinstein,et al.  Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Y. Carmeli,et al.  Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel , 2011, Infection Control &#x0026; Hospital Epidemiology.

[37]  Y. Carmeli,et al.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  K. To,et al.  Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. , 2008, The Journal of hospital infection.

[39]  S. Cairncross,et al.  How often do you wash your hands? A review of studies of hand-washing practices in the community during and after the SARS outbreak in 2003 , 2007, International journal of environmental health research.